OTCMKTS:TSOI Therapeutic Solutions International - TSOI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Therapeutic Solutions International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.0028 0.00 (0.00%) (As of 03/21/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.0027▼$0.003050-Day Range$0.0028▼$0.007052-Week Range$0.00▼$0.03Volume9.58 million shsAverage Volume8.07 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest About Therapeutic Solutions International (OTCMKTS:TSOI) StockTherapeutic Solutions International, Inc. engages in the manufacture of surgical and medical devices. It develops a range of immune-modulatory agents to target cancers, enhance maternal and fetal health, and fight periodontal disease. The company was founded on August 6, 2007 and is headquartered in Elk City, ID.Read More Receive TSOI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Therapeutic Solutions International and its competitors with MarketBeat's FREE daily newsletter. Email Address TSOI Stock News HeadlinesMarch 20, 2023 | finance.yahoo.comTherapeutic Solutions International Spin Off Campbell Neurosciences Creates Saliva Based Test for Suicidal IdeationsMarch 13, 2023 | finance.yahoo.comTherapeutic Solutions International Advances Chronic Obstructive Pulmonary Disease Program by Identifying Novel B Regulatory Cell Mechanism of Action for JadiCell Universal Donor Adult Stem CellMarch 22, 2023 | Stansberry Research (Ad)The gold catalyst we’ve waited forIf you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK. March 6, 2023 | msn.comTherapeutic Solutions plans to start breast cancer trial using FloraStilbeneMarch 6, 2023 | finance.yahoo.comTherapeutic Solutions International Announces Plans to Initiate Breast Cancer Clinical Trial Using FloraStilbene™ Immune Stimulator Through Res Nova Bio SubsidiaryFebruary 21, 2023 | finance.yahoo.comTherapeutic Solutions International Launches Veltmeyer Institute for Advanced BiologicsFebruary 14, 2023 | finance.yahoo.comRes Nova Bio Leverages Immunological Similarities between Abortion Pill and Cancer Remission to Create Novel ImmunotherapyJanuary 30, 2023 | finance.yahoo.comTherapeutic Solutions International Spin Off Res Nova Bio Announces Recruitment of President and Chief Executive OfficerMarch 22, 2023 | Investing Daily (Ad)How This Trader Banked A 97% Win RateDespite the volatility of the last few years, this reclusive millionaire hasn’t closed a losing trade since July 2016. He just plugs away, executing what may be the most effective investment strategy on Earth. He turned $50K into $5.3M! Want to see the details? Click HERE to watch it for yourself. January 9, 2023 | finance.yahoo.comTherapeutic Solutions International Identifies Novel Cellular Marker Associated with Therapeutic Response to JadiCell Stem Cell TreatmentJanuary 4, 2023 | finance.yahoo.comTherapeutic Solutions International Announces Antigen Specific Blockade of Pathological Immune Response in Multiple Sclerosis Model Using "Tattoo Gun" ImmunizationDecember 5, 2022 | finance.yahoo.comTherapeutic Solutions International Announces Improvements in Autism, Amyotrophic Lateral Sclerosis and Schizophrenia Cases Treated by Veltmeyer Institute for Advanced TherapeuticsNovember 28, 2022 | finance.yahoo.comTherapeutic Solutions International Granted Broad Patent on Treatment of Neurodegenerative ConditionsNovember 14, 2022 | finance.yahoo.comTherapeutic Solutions Announces Universal Donor Myeloid Derived Suppressor Therapy Platform for Treatment of Chronic Obstructive Pulmonary Disease (COPD)November 9, 2022 | finance.yahoo.comTherapeutic Solutions International Launches Spin-Off Breathe Biologics Aimed at Curing Chronic Obstructive Pulmonary Disease (COPD)November 7, 2022 | finance.yahoo.comTherapeutic Solutions International Spin-Off Res Nova Bio Collaborates with Veltmeyer MD Inc. to Provide Breast Cancer Patients Access to Novel Cancer ImmunotherapyOctober 27, 2022 | finance.yahoo.comTherapeutic Solutions International Announces Launch of Cancer Immunotherapy Spin-Off Res Nova Bio, Inc.October 24, 2022 | finance.yahoo.comTherapeutic Solutions International Announces Successful Treatment of Epilepsy in Animal Model and Complete Cessation of Seizures in Treatment Resistant PatientOctober 3, 2022 | finance.yahoo.comTherapeutic Solutions International Identifies CD103 Expressing Dendritic Cells and Exosomes Thereof as Novel Mechanism for JadiCell Mesenchymal Stem Cell Mediated Lung ProtectionSeptember 20, 2022 | finance.yahoo.comTherapeutic Solutions International Secures Financing to Complete Current Phase III Stem Cell Clinical TrialSeptember 19, 2022 | reuters.comTSOI.PQ - Therapeutic Solutions International Inc | Stock Price & Latest News | ReutersSeptember 19, 2022 | finance.yahoo.comTherapeutic Solutions International Spin-Off Company Campbell Neurosciences Announces Successful Preclinical Studies of CampbellCell for Treatment of Bipolar DisorderSeptember 3, 2022 | marketwatch.comTherapeutic Drug Monitoring Market Size 2022 Global Growth, Trends, Industry Analysis, Key Players and Forecast to 2027 with CAGR of 9.8%August 29, 2022 | finance.yahoo.comTherapeutic Solutions International Develops Gene Silencing Therapy for Acute Respiratory Distress SyndromeAugust 25, 2022 | finance.yahoo.comTherapeutic Solutions International Files with FDA to Expand ongoing Phase III Clinical Trial to Include All Causes of Acute Respiratory Distress SyndromeAugust 23, 2022 | marketwatch.comGlobal NASH Therapeutic Drugs Market Size and Growth 2022 Analysis Report by Share, Growth Rate, Emerging Trends, and Forecast to 2028August 16, 2022 | marketwatch.comTherapeutic Enzymes Market Is Projected to RaIse a CAGR of 12.1% by 2027 | 91 Report PagesSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive TSOI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Therapeutic Solutions International and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:TSOI CUSIP883378101 CIK1419051 Webtherapeuticsolutionsint.com Phone(760) 295-7208FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesTimothy G. DixonChairman, President & Chief Executive OfficerJames VeltmeyerChief Medical OfficerFeng LinChief Scientific OfficerFamela RamosVice President-Business DevelopmentSerena RobellaSales DirectorKey Competitors3SBioOTCMKTS:TRSBFAbattis BioceuticalsOTCMKTS:ATTBFAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFAinosNASDAQ:AIMDWView All Competitors TSOI Stock - Frequently Asked Questions How have TSOI shares performed in 2023? Therapeutic Solutions International's stock was trading at $0.0060 at the beginning of 2023. Since then, TSOI stock has decreased by 54.2% and is now trading at $0.0028. View the best growth stocks for 2023 here. Are investors shorting Therapeutic Solutions International? Therapeutic Solutions International saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 92,100 shares, an increase of 79.5% from the February 13th total of 51,300 shares. Based on an average daily volume of 7,109,900 shares, the short-interest ratio is presently 0.0 days. View Therapeutic Solutions International's Short Interest. What other stocks do shareholders of Therapeutic Solutions International own? Based on aggregate information from My MarketBeat watchlists, some companies that other Therapeutic Solutions International investors own include Carnival Co. & (CCL), Korea Electric Power (KEP), Redwood Trust (RWT), Signet Jewelers (SIG), Goldman Sachs Physical Gold ETF (AAAU), Aurora Cannabis (ACB), AeroVironment (AVAV), Booking (BKNG), Chimera Investment (CIM) and Enterprise Products Partners (EPD). What is Therapeutic Solutions International's stock symbol? Therapeutic Solutions International trades on the OTCMKTS under the ticker symbol "TSOI." How do I buy shares of Therapeutic Solutions International? Shares of TSOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Therapeutic Solutions International's stock price today? One share of TSOI stock can currently be purchased for approximately $0.00. How can I contact Therapeutic Solutions International? Therapeutic Solutions International's mailing address is 4093 Oceanside Blvd Ste B, OCEANSIDE, CA 92056-5816, United States. The official website for the company is therapeuticsolutionsint.com. The company can be reached via phone at (760) 295-7208. This page (OTCMKTS:TSOI) was last updated on 3/22/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.